Abbott starts Herculink renal stent study
This article was originally published in Clinica
Executive Summary
The first patient has undergone treatment in a clinical trial of Abbott's Herculink renal stent. The US-based HERCULES (Herculink Elite Cobalt Chromium Renal Stent Trial to Demonstrate Efficacy and Safety) study is designed to test the product in patients with renal artery stenosis (RAS).